SHOP BONE SUPPORT FORMULA 2
Focus on protein, resistance training, and sleep before making medication changes, and bring your tracking data to your provider so decisions are guided by evidence rather than frustration
In the STEP-4 trial (N=803), patients who continued semaglutide 2.4 mg maintained their weight loss, while those who switched to placebo regained an average of 6.9% body weight over 48 weeks, underscoring that this is a chronic therapy rather than a short course
Your doctor may suggest slowing down the dose escalation, temporarily reducing your Retatrutide dose, or pausing treatment until the symptoms clear
Subjects were recruited by self-selection at Cleveland Clinic
Some people begin to see results in the first few weeks